Vitrified Porcelain Tiles Sample Clauses

Vitrified Porcelain Tiles. 13.6.1 Wherever shown on drawing/indicated in schedule of finishes, Vitrified Porcelain Tiles shall be laid over 15mm thick screed bedding layer in CM 1:6 over 75mm thick PCC 1:4:8 type D2 over 75mm thick hardcore of stone aggregate n exc 63mm over rammed earth. 13.6.2 Vitrified polished porcelain floor tiles shall be of Ist quality. These vitrified tiles are classified undergroup B1a of the International Standard for ceramic tiles ISO: 13006. Tiles shall be hard, dense, impervious andfrost resistant. Water absorption of tiles shall be less than 0.5% and flexural strength (Modulus of Rupture)shall be more than 35 N/Sqmm. Vitrified polished porcelain floor tiles shall be provided of sizes, colour,shades, texture and designs as approved by GE and if size not indicated it shall be 600mm x 600 mm/ 605 x 605 mm.The thickness shall be as specified by the manufacturer but not less than 10mm.
Sample 1
AutoNDA by SimpleDocs
Vitrified Porcelain Tiles. 13.2.1. Vitrified polished porcelain floor tile shall be first quality. These tiles are classified under group B1a of the International Standard for ceramic tiles ISO-13006. Tiles shall be hard, dense, impervious and frost resistant. Water absorption of tiles shall be less than 0.5% and flexural strength (Modulus of Rupture) shall be more than 35 N/Sqmm. Vitrified polished porcelain floor tile shall be provided of size, colour, shade, texture and designs as indicated in Schedule “A.” If the size of tile is not mentioned any where in the tender documents then size of tile will be 600 x 600 mm / 605 x 605 mm of thickness as specified but in no case it shall be less than 10 mm.
Sample 1
Vitrified Porcelain Tiles. 16.3.1 Refer para 13.15 of MES Schedule Part-I, 2009 as applicable. 16.3.2 Workmanship : Refer para 13.41 of MES Schedule Part-I as applicable. TECHNICAL SPECIFICATIONS OF ANTISKID AND GLAZED CERAMIC FLOOR AND WALL TILES SKIRTING/DADO Ser No Characteristics Floor tiles norms Method of Testing 1 Deviation and surface quality (a) Deviation in length + 0.4% EN-98/IS-13630 (b) Deviation in thickness + 0.4% - do - (c) Squareness + 0.4% - do - (d) Straightness of sides + 0.4% - do - (e) Surface Flatness + 0.4% - do - (f) Surface Quality 1 Conforms 2 Physical Properties (a) Water Absorption 4-5% EN-99/IS-13630 Part 2 (b) Bending Strength > 3000 Kg/cm2 EN-100/IS-13630 Part 6 (c) Scratch resistance (Moh's Scale) > 5 EN-154/IS-13630 Part II (d) Resistance of surface abrasion PEI Grade V EN- (e) Crazing Resistance Passes 4 Cycles EN-105/IS-13630 Part 9 3 Chemical Properties (a) Resistance to staining Conforms EN-122/IS-13630 Part 8 (b) Resistance to house hold chemicals Conforms EN-122/IS-13630 Part 8 4 Thermal Specifications (a) Thermal shock resistance Conforms EN-104/IS-13630 Part 5 (b) Thermal Expansion Conforms EN-103/IS-13630 Part 4
Sample 1

Related to Vitrified Porcelain Tiles

  • Mail Order Catalog Warnings In the event that, the Settling Entity prints new catalogs and sells units of the Products via mail order through such catalogs to California consumers or through its customers, the Settling Entity shall provide a warning for each unit of such Product both on the label in accordance with subsection 2.4 above, and in the catalog in a manner that clearly associates the warning with the specific Product being purchased. Any warning provided in a mail order catalog shall be in the same type size or larger than other consumer information conveyed for such Product within the catalog and shall be located on the same display page of the item. The catalog warning may use the Short-Form Warning content described in subsection 2.3(b) if the language provided on the Product label also uses the Short-Form Warning.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Fish and Wildlife Service 2002c. Colorado pikeminnow (Ptychocheilus lucius) recovery goals: amendment and supplement to the Colorado Squawfish Recovery Plan.

  • Nepotism No employee shall be directly supervised by a member of his/her immediate family. “

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • DRUGS & ALCOHOL Any incidents concerning drugs and/or alcohol shall be dealt with in accordance with the policy of the Building Industry Group Drug and Alcohol Safety and Rehabilitation Program as detailed in Appendix D of this Agreement.

  • Musculoskeletal Injury Prevention and Control The hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

  • Vlastnictví Zdravotnické zařízení si ponechá a bude uchovávat Zdravotní záznamy. Zdravotnické zařízení a Zkoušející převedou na Zadavatele veškerá svá práva, nároky a tituly, včetně práv duševního vlastnictví k Důvěrným informacím (ve smyslu níže uvedeném) a k jakýmkoli jiným Studijním datům a údajům.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Internationalized Domain Names (IDNs) 4.1. Registry Operator must offer Registrars support for handling IDN registrations in EPP. 4.2. Registry Operator will not offer variant IDNs.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!